Account

Industry resources and insights

Sort by year
  • All time
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019 and older
Insider Insights
26.11.2025
ISPOR Europe 2025: Key Insights, Research Posters ...

ISPOR Europe 2025 brought together global HTA bodies, payers, industry leaders and patient organisat...

Read more
Articles
26.11.2025
2025 Market Access Check-In: Evaluating the Impact...

2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...

Read more
Articles
03.11.2025
Designing Payer-Ready Trials in 2025: Five Decisio...

Clinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...

Read more
Articles
21.10.2025
Comparator Choice: The Question That Defines Marke...

Every payer ultimately asks the same question: “Compared with what?” This single question shapes...

Read more
Poster
15.10.2025
What Are the Likely PICOs for Tovorafenib and Lifi...

Objectives:  ​​EUHTA regulation has applied from the 1st January 2025 for oncology pr...

Read more
Poster
15.10.2025
How the EU JCA could interface with Regional Prici...

Objectives: ​​To analyse how the mandatory EU Joint Clinical Assessment (JCA) could in...

Read more
Load more
Browse by topic
  • Advanced Therapy Medicinal Products
  • Alzheimer’s
  • BD Assessments
  • Biosimilars
  • Biotech
  • Devices & Diagnostics
  • Digital Health
  • Early Access
  • Early Payer Dialogue
  • Emerging & Developing Markets
  • Funding
  • Gene Therapy & ATMPs
  • HTA
  • International Reference Pricing
  • ISPOR
  • Launch
  • Managed Entry Agreements
  • Market Access Trends
  • Medicine manufacturing
  • MFN
  • NICE
  • Oncology
  • Orphan Drugs
  • PMA Trends
  • Pricing
  • Rare Diseases
  • Real World Evidence
  • Team Remap
  • Tendering & Procurement
  • Training
  • United States
Content type
  • All
  • Articles
  • Case Studies
  • Checklist
  • Guide
  • Insider Insights
  • News
  • Poster
  • Publications
  • Webinar
Subscribe
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
Consent

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch